MARKET

LGND

LGND

Ligand Pharma
NASDAQ
202.91
-8.57
-4.05%
After Hours: 200.00 -2.91 -1.43% 19:50 03/13 EDT
OPEN
211.48
PREV CLOSE
211.48
HIGH
214.80
LOW
200.69
VOLUME
273.48K
TURNOVER
--
52 WEEK HIGH
227.92
52 WEEK LOW
93.58
MARKET CAP
4.05B
P/E (TTM)
33.09
1D
5D
1M
3M
1Y
5Y
1D
Ligand Pharmaceuticals CFO Octavio Espinoza Disposes of Common Shares
Reuters · 8h ago
Ligand Pharmaceuticals Down Over 9%, on Pace for Largest Percent Decrease Since January 2022 -- Data Talk
Dow Jones · 1d ago
Ligand Pharmaceuticals Is A Low-Risk Way To Bet On Biopharma Growth: Analyst
Benzinga · 2d ago
Oracle, Nike upgraded: Wall Street’s top analyst calls
TipRanks · 2d ago
LIGAND PHARMACEUTICALS INC <LGND.O>: BOFA GLOBAL RESEARCH INITIATES COVERAGE WITH BUY RATING; PRICE OBJECTIVE $244
Reuters · 2d ago
Ligand gains new Buy from BofA on high-margin, less risky narrative
Seeking Alpha · 2d ago
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
Benzinga · 2d ago
Ligand Pharmaceuticals Initiated at Buy by B of A Securities
Dow Jones · 2d ago
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.